The DGF is a major challenge for allograft survival as it potentially leads to acute rejection and chronic allograft nephropathy. The DGF is a manifestation of acute kidney injury (AKI) following a renal transplantation procedure. As it is an acute clinical incidence, patients will experience a 10% increase in serum creatinine levels in the first 48 hours postoperatively and require hemodialysis within the first week after transplantation (
16). This is often used as the basis for the diagnosis of DGF in posttransplant patients. Although the definition of DGF is sporadic among studies, it still reflects the AKI process that occurs in patients (
17).
In a literature review, the DGF mechanism has been described as a failure of the reperfusion process (i.e., ischemia) or renal reperfusion success, followed by the activation of immune cells, which causes an acute rejection event (
16). This process causes AKI, which manifests as a glomerular filtration rate decrease, accompanied by an increase of serum creatinine levels. A decreased rate of kidney filtration that occurs in DGF patients causes low urine production. This event has been documented in various clinical studies (
18).
A meta-analysis showed a 41% increased risk of long-term graft failure in DGF patients. The DGF was also associated with a 38% increased risk of acute rejection in the first year and resulted in higher serum creatinine concentrations at 3.5 years of follow-up (
18). In this case, DGF is an essential clinical outcome after a kidney transplant, which requires the attention of patients and physicians before performing a transplant. The early detection of DGF patients is necessary to be conducted.
This study systematically reviewed the relationship between the UOP1 and DGF. Almost all studies which reported the relationship between these two variables showed a significant relationship between the UOP1 and DGF. Patients with the UOP1 lower than the optimum cut-off in each study were at a higher risk of developing DGF, with an OR of 29.61 (8.07 - 108.60). Multivariate analysis by Parikh et al. (
15) also demonstrated that low UOP1 was a risk factor for DGF, with an OR of 11.7 (0.1 - 13). All studies published after 2010 reported the OR ≥ 40. Nielsen et al. analyzed the incidence of DGF with the primary risk factor assessed as plasma neutrophil gelatinase-associated lipocalin in the first 24-hour postoperative urine. The aforementioned clinical trial study used a deceased donor with a median age of 58 (51 - 65) years and showed that all patients with low urine output (based on the optimum cut-off) experienced DGF. Only 7 out of 65 patients with normal urine output (based on optimum cut-off) required dialysis in the first postoperative week (
8). This finding makes the aforementioned study have a huge effect estimate, compared to others.
In predicting patients experiencing DGF, the UOP1 has good sensitivity and specificity. All the studies agreed that the sensitivity of the UOP1 was high, and no study reported it below 70%. Pajek et al., prospectively assessing patients after renal transplantation from deceased and living donors, demonstrated that all patients with DGF had the UOP1 lower than the optimum cut-off (sensitivity of 100%) (
11). Hollmen et al., with a total of 71 patients and homogeneous (only deceased donors) treatment, showed a UOP1 sensitivity of 91% (0.83 - 0.96) (
12). The aforementioned two studies had the most prominent effect estimate among the three other studies in the current meta-analysis.
The UOP1 performance in ruling-in DGF patients was not as good as the performance in ruling-out DGF patients. The specificity reported by the examined studies varies greatly. The use of optimum cut-off in each study is considered to be the cause of this variability. Each study was more concerned with high sensitivity, as in clinical settings false positive is regarded to be better than false negative (i.e., misdiagnosis). Nevertheless, the specificity value in this study was still high and quite helpful in ruling-in DGF patients.
Several factors observed to confound this systematic review are the heterogeneity of study designs, sample size, publication years, and optimum cut-offs that vary between the studies. This study involved two retrospective studies indicating that the obtained data were only based on medical records. The number of samples between studies also varied within tens to hundreds. Additionally, the number of studies with similar effect estimates was also small; therefore, the number of studies that can be analyzed quantitatively was small. Furthermore, some studies did not report the criteria used to establish which patients needed hemodialysis. Different optimum cut-offs for each study also contributed to the performance bias of this meta-analysis.
7.1. Conclusions
In conclusion, the UOP1 has a strong and significant association with DGF events and is a good parameter in predicting the incidence of DGF in patients after renal transplantation, with high sensitivity and specificity.